The negative impact of anemia on radiotherapy and chemoradiation outcomes

Seminars in Hematology

Volumn 38, Issue 3 SUPPL. 7, 2001, Pages 8-15

  Shasha, Daniel ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DEATH; CONFERENCE PAPER; HEAD AND NECK CANCER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SOLID TUMOR; SURVIVAL RATE;

EID: 0034855507     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0037-1963(01)90125-8     Document Type: Conference Paper

References (47)

1. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials
2. Principles of cancer management: Radiation therapy
3. Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition
4. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition
5. Contribution of anemia to fatigue in the cancer patient
6. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
7. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome
8. Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix
9. 2 during early radiotherapy in cervical cancers: Improved local control in primarily hypoxic tumors with "reoxygenation" and the impact of hemoglobin
10. Blood flow and oxygenation status of human tumors: Clinical investigations
11. Physiologic mechanisms of therapeutic resistance: Blood flow and hypoxia
12. T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control
13. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status
14. Reduced oxygen enhancement ratio at low doses of ionizing radiation
15. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation
16. Tumor hypoxia, the physiologic link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis
17. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
18. Oxygen delivery: Implications for the biology and therapy of solid tumors
19. Prognostic significance of anemia and role of erythropoietin in radiation therapy
20. 2 study
21. 2 predicts survival in advanced cancer of the uterine cervix
22. Oxygenation predicts radiation response and survival in patients with cervix cancer
23. Prevalence of anemia in cancer patients undergoing radiotherapy
24. Radiotherapy and anaemia - The clinical experience
25. The significance of anemia in clinical radiation therapy
26. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study
27. Pretreatment hemoglobin level influences local control and survival of T1-T 2 squamous cell carcinomas of the glottic larynx
28. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27
29. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
30. The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate
31. The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on RTOG trial #79-15
32. Does initial hemoglobin level modify the efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer
33. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients
34. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
35. Definitive evidence for hypoxic cells influencing cure in cancer therapy
36. Transfusion medicine: Blood transfusion
37. A new approach to managing chemotherapy-related anemia: Nursing implications of epoetin alfa
38. Special report: Transfusion risks
39. Blood transfusions and prognosis in colorectal cancer
40. Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery
41. Randomised controlled trial comparing transfusion of leucocyte-depleted or bully-coat-depleted blood in surgery for colorectal cancer
42. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery
43. Erythropoietin increases hemoglobin in cancer patients during radiation therapy
44. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer
45. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Final report of a randomized, open-labelled, phase II trial
46. R-HuErythropoetin supply increases efficacy of neoadjuvant radiochemotherapy in patients wirh oral squamous cell carcinoma
47. Impact of hemoglobin (Hgb) level and use of recombinant human erythropoietin (r-HuEPO) on response to neoadjuvant chemoradiation therapy, tumor control, and survival in patients with oral or oropharyngeal squamous cell carcinoma (SCCA)